NO20054607L - Nitrogenholdig heterosyklisk derivat som har 2,6-disubstituert styryl - Google Patents
Nitrogenholdig heterosyklisk derivat som har 2,6-disubstituert styrylInfo
- Publication number
- NO20054607L NO20054607L NO20054607A NO20054607A NO20054607L NO 20054607 L NO20054607 L NO 20054607L NO 20054607 A NO20054607 A NO 20054607A NO 20054607 A NO20054607 A NO 20054607A NO 20054607 L NO20054607 L NO 20054607L
- Authority
- NO
- Norway
- Prior art keywords
- heterocyclic derivative
- containing heterocyclic
- nitrogen
- pharmaceutically acceptable
- styryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/12—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with only hydrogen atoms attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/38—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003061758 | 2003-03-07 | ||
| PCT/JP2004/002842 WO2004078715A1 (ja) | 2003-03-07 | 2004-03-05 | ２，６－ジ置換スチリルを有する含窒素へテロ環誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20054607D0 NO20054607D0 (no) | 2005-10-06 |
| NO20054607L true NO20054607L (no) | 2005-12-06 |
Family
ID=32958970
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20054607A NO20054607L (no) | 2003-03-07 | 2005-10-06 | Nitrogenholdig heterosyklisk derivat som har 2,6-disubstituert styryl |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8044206B2 (ru) |
| EP (1) | EP1602645A4 (ru) |
| JP (1) | JP4610480B2 (ru) |
| KR (1) | KR20050114641A (ru) |
| CN (1) | CN100516040C (ru) |
| AU (1) | AU2004218115A1 (ru) |
| BR (1) | BRPI0408136A (ru) |
| CA (1) | CA2517081A1 (ru) |
| MX (1) | MXPA05009290A (ru) |
| NO (1) | NO20054607L (ru) |
| RU (1) | RU2333200C2 (ru) |
| WO (1) | WO2004078715A1 (ru) |
| ZA (1) | ZA200507486B (ru) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004078715A1 (ja) | 2003-03-07 | 2004-09-16 | Astellas Pharma Inc. | ２，６－ジ置換スチリルを有する含窒素へテロ環誘導体 |
| CA2541949A1 (en) | 2003-10-07 | 2005-05-26 | Renovis, Inc. | Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| RU2347775C2 (ru) * | 2004-09-01 | 2009-02-27 | Астеллас Фарма Инк. | Пиперидиновое производное или его фармацевтически приемлемая соль |
| US7576099B2 (en) | 2005-02-28 | 2009-08-18 | Renovis, Inc. | Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| BRPI0606365A2 (pt) * | 2005-02-28 | 2017-06-27 | Renovis Inc | composto ou um sal, solvato ou pró-droga farmaceuticamente aceitável do mesmo e estereoisômeros e tautômeros do mesmo, composição farmacêutica, métodos para prevenir, tratar, melhorar ou controlar uma doença ou condição e para preparar um composto, uso de um composto ou um sal, solvato ou composição farmaceuticamente aceitável do mesmo, método de tratamento de um mamífero, e, combinação |
| AU2006264649A1 (en) * | 2005-06-30 | 2007-01-11 | Prosidion Limited | GPCR agonists |
| GB201106817D0 (en) | 2011-04-21 | 2011-06-01 | Astex Therapeutics Ltd | New compound |
| WO2013018929A1 (en) | 2011-08-04 | 2013-02-07 | Takeda Pharmaceutical Company Limited | Nitrogen-containing heterocyclic compound |
| GB201218850D0 (en) | 2012-10-19 | 2012-12-05 | Astex Therapeutics Ltd | Bicyclic heterocycle compounds and their uses in therapy |
| GB201218864D0 (en) | 2012-10-19 | 2012-12-05 | Astex Therapeutics Ltd | Bicyclic heterocycle compounds and their uses in therapy |
| US9980973B2 (en) | 2012-10-19 | 2018-05-29 | Astex Therapeutics Limited | Bicyclic heterocycle compounds and their uses in therapy |
| GB201218862D0 (en) | 2012-10-19 | 2012-12-05 | Astex Therapeutics Ltd | Bicyclic heterocycle compounds and their uses in therapy |
| MX2016008131A (es) | 2013-12-20 | 2016-09-16 | Astex Therapeutics Ltd | Compuestos heterociclos biciclicos y sus usos en terapia. |
| US9950989B2 (en) | 2014-02-14 | 2018-04-24 | Toa Eiyo Ltd. | Cyclic hydrocarbon compound |
| EP3277704A1 (en) | 2015-03-31 | 2018-02-07 | Allergan, Inc. | Cyclosporins modified on the mebmt sidechain by heterocyclic rings |
| CN108503579B (zh) * | 2018-03-28 | 2021-03-26 | 南京医科大学 | 芬太尼类似物及其应用 |
| CN114948953A (zh) * | 2021-06-29 | 2022-08-30 | 四川大学华西医院 | 一种杂原子取代芳香类化合物及其盐的用途 |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3658797A (en) * | 1968-08-06 | 1972-04-25 | Lilly Co Eli | Novel 5-nitroimidazole antiparasitic agents |
| GB2069481B (en) | 1980-02-13 | 1983-07-27 | Farmos Oy | Substituted imidazole derivatives |
| GB2092569B (en) * | 1981-02-05 | 1984-09-19 | Farmos Oy | Substituted imidazole derivatives and their preparation and use |
| GB2101114B (en) | 1981-07-10 | 1985-05-22 | Farmos Group Ltd | Substituted imidazole derivatives and their preparation and use |
| FR2522325B1 (fr) | 1982-02-26 | 1985-08-09 | Delalande Sa | Nouveaux derives aryliques de la piperazine, de l'homopiperazine et de n,n'-dialkyl diamino-1,2 ethane, leur procede de preparation et leur application en therapeutique |
| JPS60193966A (ja) | 1984-03-13 | 1985-10-02 | Ss Pharmaceut Co Ltd | Ν−ニコチノイルピペラジン誘導体及びその製造法 |
| JPH0631230B2 (ja) | 1987-02-20 | 1994-04-27 | 山之内製薬株式会社 | 飽和ヘテロ環カルボン酸アミド誘導体 |
| CN1030415A (zh) | 1987-02-20 | 1989-01-18 | 山之内制药株式会社 | 饱和的杂环碳酰胺衍生物和它的制备方法 |
| JPH01316359A (ja) | 1988-03-23 | 1989-12-21 | Idemitsu Kosan Co Ltd | ピリジン誘導体および該誘導体を有効成分とする殺虫・殺ダニ剤 |
| ES2096651T3 (es) | 1990-06-07 | 1997-03-16 | Merrell Pharma Inc | Derivados de 1-piperidinil alcanoilarilsulfonamida. |
| JPH04342579A (ja) | 1991-05-20 | 1992-11-30 | Hiroyoshi Hidaka | １−アリールスルホニルピペラジン類及び薬剤として許容され得るその酸付加塩 |
| JP3134552B2 (ja) | 1991-12-13 | 2001-02-13 | 宇部興産株式会社 | シンナミルピペラジン誘導体、その製法及び農園芸用殺菌剤 |
| EP0551617A3 (en) | 1991-12-13 | 1993-11-03 | Ube Industries | Cinnamyl piperazine derivatives method of manufacturing the same and agricultural/horticultural fungicides containing cinnamyl piperazine derivatives |
| US5240943A (en) | 1991-12-19 | 1993-08-31 | G. D. Searle & Co. | Benzopyran class iii antiarrhythmic agents |
| GB9226111D0 (en) | 1992-12-15 | 1993-02-10 | Smithkline Beecham Plc | Madicaments |
| WO1995024390A1 (en) | 1994-03-11 | 1995-09-14 | Smithkline Beecham Plc | Novel phenyl(-alkyl/alkoxy)-1-aminoalkyl-substituted piperidines and pyrrolidines as calcium channel antagonists |
| FR2726267B1 (fr) | 1994-10-26 | 1998-01-02 | Smithkline Beecham Lab | Nouveaux agents anti-arythmiques, compositions pharmaceutiques les contenant, et procede pour les preparer |
| ATE240942T1 (de) | 1995-11-17 | 2003-06-15 | Merck & Co Inc | Neue substituierte aryl-verbindungen als acetylcholine receptors modulatoren |
| TWI240627B (en) | 1996-04-26 | 2005-10-01 | Chugai Pharmaceutical Co Ltd | Erythropoietin solution preparation |
| TW544448B (en) * | 1997-07-11 | 2003-08-01 | Novartis Ag | Pyridine derivatives |
| JP3593031B2 (ja) | 1997-08-14 | 2004-11-24 | エフ．ホフマン−ラ ロシュ アーゲー | 神経学的障害に対する複素環式ビニルエーテル |
| WO2000012074A2 (en) | 1998-08-28 | 2000-03-09 | Scios Inc. | Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase |
| EP1180513A4 (en) | 1999-04-28 | 2002-07-10 | Takeda Chemical Industries Ltd | CYCLIC AMID DERIVATIVES, METHOD FOR PRODUCING THE SAME AND USE THEREOF |
| KR20020087041A (ko) | 1999-07-28 | 2002-11-21 | 아벤티스 파마슈티칼스 프로덕츠 인크. | 치환된 옥소아자헤테로사이클릴 화합물 |
| AU780009B2 (en) | 1999-08-31 | 2005-02-24 | Merck Sharp & Dohme Corp. | Heterocyclic compounds and methods of use thereof |
| JP4282048B2 (ja) * | 2000-01-20 | 2009-06-17 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 新規ピペリジン化合物およびその医薬 |
| WO2001053288A1 (fr) * | 2000-01-20 | 2001-07-26 | Eisai Co., Ltd. | Nouveaux composes de piperidine et medicaments contenant ces composes |
| AU2001251147A1 (en) | 2000-03-31 | 2001-10-15 | Dupont Pharmaceuticals Company | Succinoylamino heterocycles as inhibitors of abeta protein production |
| BR0115871A (pt) | 2000-12-04 | 2003-10-28 | Hoffmann La Roche | Derivados de feniletenila ou feniletinila como antagonistas de receptores de glutamato |
| PT1368358E (pt) * | 2001-02-21 | 2007-01-31 | Janssen Pharmaceutica Nv | Derivados de isoxazolina como anti-depressivos |
| CN1529599A (zh) | 2001-06-14 | 2004-09-15 | ��̩��˹ҩ��ɷ�����˾ | 可用于治疗神经元损伤的无环哌嗪和哌啶衍生物 |
| EP2262050B1 (en) | 2001-07-06 | 2013-09-04 | Nippon Kayaku Kabushiki Kaisha | Photoelectric conversion element sensitized with methine dyes |
| CN1941694B (zh) | 2001-07-17 | 2011-04-20 | 夏普株式会社 | 生成用于检测在处理期间加密数据的虚假改造的数据的设备及方法 |
| US6995144B2 (en) * | 2002-03-14 | 2006-02-07 | Eisai Co., Ltd. | Nitrogen containing heterocyclic compounds and medicines containing the same |
| CN2562229Y (zh) * | 2002-07-23 | 2003-07-23 | 昆山新力精密五金有限公司 | 散热器中的散热叶片之装置 |
| JPWO2004011430A1 (ja) * | 2002-07-25 | 2005-11-24 | アステラス製薬株式会社 | ナトリウムチャネル阻害剤 |
| WO2004037817A1 (ja) | 2002-10-25 | 2004-05-06 | Mitsubishi Pharma Corporation | Ｎ−オキシド化合物 |
| WO2004078715A1 (ja) | 2003-03-07 | 2004-09-16 | Astellas Pharma Inc. | ２，６－ジ置換スチリルを有する含窒素へテロ環誘導体 |
| RU2347775C2 (ru) * | 2004-09-01 | 2009-02-27 | Астеллас Фарма Инк. | Пиперидиновое производное или его фармацевтически приемлемая соль |
-
2004
- 2004-03-05 WO PCT/JP2004/002842 patent/WO2004078715A1/ja active Application Filing
- 2004-03-05 CN CNB2004800059211A patent/CN100516040C/zh not_active Expired - Fee Related
- 2004-03-05 BR BRPI0408136-6A patent/BRPI0408136A/pt not_active IP Right Cessation
- 2004-03-05 KR KR1020057016695A patent/KR20050114641A/ko not_active Application Discontinuation
- 2004-03-05 CA CA002517081A patent/CA2517081A1/en not_active Abandoned
- 2004-03-05 ZA ZA200507486A patent/ZA200507486B/xx unknown
- 2004-03-05 AU AU2004218115A patent/AU2004218115A1/en not_active Abandoned
- 2004-03-05 MX MXPA05009290A patent/MXPA05009290A/es not_active Application Discontinuation
- 2004-03-05 JP JP2005503134A patent/JP4610480B2/ja not_active Expired - Fee Related
- 2004-03-05 US US10/548,197 patent/US8044206B2/en not_active Expired - Fee Related
- 2004-03-05 RU RU2005131014/04A patent/RU2333200C2/ru not_active IP Right Cessation
- 2004-03-05 EP EP04717835A patent/EP1602645A4/en not_active Withdrawn
-
2005
- 2005-10-06 NO NO20054607A patent/NO20054607L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US20070099956A1 (en) | 2007-05-03 |
| RU2005131014A (ru) | 2006-05-10 |
| ZA200507486B (en) | 2007-03-28 |
| CN100516040C (zh) | 2009-07-22 |
| US8044206B2 (en) | 2011-10-25 |
| JP4610480B2 (ja) | 2011-01-12 |
| CN1756740A (zh) | 2006-04-05 |
| WO2004078715A1 (ja) | 2004-09-16 |
| CA2517081A1 (en) | 2004-09-16 |
| EP1602645A4 (en) | 2008-12-03 |
| KR20050114641A (ko) | 2005-12-06 |
| RU2333200C2 (ru) | 2008-09-10 |
| BRPI0408136A (pt) | 2006-03-01 |
| JPWO2004078715A1 (ja) | 2006-06-08 |
| AU2004218115A1 (en) | 2004-09-16 |
| MXPA05009290A (es) | 2006-05-31 |
| NO20054607D0 (no) | 2005-10-06 |
| EP1602645A1 (en) | 2005-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20054607L (no) | Nitrogenholdig heterosyklisk derivat som har 2,6-disubstituert styryl | |
| NO20053356D0 (no) | Aminindazolderivater og anvendelse derav som kinaseinhibitorer. | |
| BRPI0408784A (pt) | método para usar um composto | |
| DK2130537T3 (da) | N3-alkylerede benzimidazolderivater som MEK-inhibitorer | |
| NO20050665L (no) | Pyrrolidonderivater som MAOE inhibitoere | |
| NO20044866L (no) | Pyrazolo-pyrimidin-anilin-forbindelser anvendelige som kinase-inhibitorer | |
| DK1789419T3 (da) | Gyraseinhibitorer og anvendelser deraf | |
| DK1527050T3 (da) | Quinolin-derivater og deres anvendelse som mycobakterielle inhibitorer | |
| DK1638970T3 (da) | Pyrid (2, 1-A)-isoquinolinderivater som DPP-IV-inhibitorer | |
| IL172542A0 (en) | 2-hydroxymethyl-3,4,5-trihydroxy-1-benzilpiperidine derivatives as inhibitors of glucosylceramide | |
| GEP20084437B (en) | Novel lincomycin derivatives possessing antimicrobial activity | |
| HRP20050075A2 (en) | Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure | |
| TW200733963A (en) | Cough inhibitor | |
| DK1511718T3 (da) | N-acylaminobenzenderivater som selektive monoaminoxidase B-inhibitorer | |
| DK1523473T3 (da) | Indolinderivater substitueret i position 6, deres fremstilling og anvendelse som lægemiddel. | |
| ITMI20030287A1 (it) | Indazolammidi dotate di attivita' analgesica metodo, per | |
| DK1487802T3 (da) | 2,3-diaryl-pyrazolidin-derivater som neurotensin-nedbrydende enzyminhibitorer | |
| EE05529B1 (et) | Ravimikoostis, mis on valmistatud prdtranskriptaasi inhibiitori ja meldooniumi baasil | |
| MXPA05009759A (es) | Combinacion de amidas de acidos fenilcarboxilicos e inhibidores del canal de ikr y su uso para tratar arritmias auriculares. | |
| NO20045437L (no) | Medikamenter for behandling av akutte dysfunksjoner i portavenesirkulasjon og hepatisk sirkulasjon | |
| WO2004056353A3 (en) | Device and method for delivering mmp inhibitors | |
| WO2004026930A3 (en) | The method for reducing inflammation using sti-571 or its salt | |
| DK1358182T3 (da) | Diazocin-derivater og anvendelsen deraf som tryptase-inhibitorer | |
| NO20052192D0 (no) | Substituerte 1,4-di-piperidin-4-yl-piperazinderivater og deres anvendelse som neurokininatagonister | |
| UY27824A1 (es) | Nueva formulación para la administración parenteral de crobenetina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |